NR: How Does It Subtly Reverse Organ Aging?
In research on anti-aging mechanisms, nicotinamide riboside (NR), a precursor of NAD⁺, has gradually attracted increasing attention from scientific institutions. In September 2023, a national invention patent related to the application of NR in delaying aging was officially published (Patent No. 202311230678.4).
This patent was jointly developed by several domestic research institutions. Based on fundamental biological research and experimental data from multiple premature aging models, it systematically demonstrated the potential role of NR in improving mitochondrial function and delaying cellular and tissue aging. The study spans multiple dimensions, from the cellular level to whole organs, providing important technical support for the application of NR.
The patent research indicates that NR can improve mitochondrial status and enhance cellular viability in various premature aging cell models. In stem cell models of Cockayne syndrome (CS hMSCs), NR significantly reduced the proportion of SA-β-gal–positive cells, a classical marker of cellular senescence. Meanwhile, in human arterial endothelial cells (hAECs), NR enhanced cellular self-renewal capacity.
These data support a positive role of NR in maintaining cellular function and delaying aging, particularly showing stable effects in regulating energy metabolism and promoting cellular renewal.
In addition, the following effects were observed:
Reduced accumulation of protein aggregates (aggresomes) in the brain, heart, lungs, liver, and kidney tissues;
Downregulation of inflammatory factor expression and alleviation of chronic multi-organ inflammation.
These findings indicate that NR acts on multiple aging-related pathways and can, to a certain extent, delay degenerative changes in tissues and organs.
Through bioinformatics analysis, the study further revealed differential gene expression changes induced by NR at the tissue level. The data showed that white adipose tissue (WAT), blood vessels, and the heart were particularly responsive to NR treatment, with more than 18% of aging-related genes being reversed following NR intervention.
Notably, NR significantly downregulated several transcription factors associated with inflammation and immune responses, such as Cebpb, Rela, and Stat2, thereby suppressing chronic inflammatory responses at the gene regulation level. This regulatory mechanism not only enhances the stability of NR in aging intervention but also highlights its tissue-targeted characteristics as a therapeutic strategy.
Unlike some anti-aging compounds, long-term use of NR in animal models did not result in obvious adverse effects. The research suggests that NR exhibits relatively clear tissue targeting and regulatory mechanisms, with controllable safety risks. This provides a solid foundation for its translation into functional foods, nutritional supplements, and medical-grade raw materials.
As one of the early domestic enterprises engaged in NAD⁺ precursor materials, Bontac Bioengineering (Shenzhen) Co., Ltd. has accumulated extensive experience in NR production and process optimization. Its NR products feature high purity, low impurity levels, and customizable specifications, meeting a wide range of needs from dietary supplements to scientific research applications.
With the gradual disclosure of more NR-related patents and continued technological advancement among upstream raw material suppliers, the technical maturity of NR is steadily improving, and its role in human health intervention is expected to become increasingly clear.
For individuals concerned with cellular health, tissue function, and chronic inflammation control, NR is expected to become a more standardized and scientifically grounded nutritional intervention option in the future.
This patent was jointly developed by several domestic research institutions. Based on fundamental biological research and experimental data from multiple premature aging models, it systematically demonstrated the potential role of NR in improving mitochondrial function and delaying cellular and tissue aging. The study spans multiple dimensions, from the cellular level to whole organs, providing important technical support for the application of NR.
Part 01
NR Improves Mitochondrial Function
The patent research indicates that NR can improve mitochondrial status and enhance cellular viability in various premature aging cell models. In stem cell models of Cockayne syndrome (CS hMSCs), NR significantly reduced the proportion of SA-β-gal–positive cells, a classical marker of cellular senescence. Meanwhile, in human arterial endothelial cells (hAECs), NR enhanced cellular self-renewal capacity.
These data support a positive role of NR in maintaining cellular function and delaying aging, particularly showing stable effects in regulating energy metabolism and promoting cellular renewal.
Part 02
Reversal and Protection of Multiple Organs by NR
Beyond its effects at the cellular level, NR also demonstrated notable anti-aging capabilities across multiple tissues and organs. Experimental results showed that long-term NR administration in animal models slowed fibrotic progression in various organs, including brown adipose tissue, heart, skeletal muscle, lungs, and liver.In addition, the following effects were observed:
Reduced accumulation of protein aggregates (aggresomes) in the brain, heart, lungs, liver, and kidney tissues;
- Decreased lipid droplet area in brown adipose tissue, as well as reduced glomerular and alveolar size;
Downregulation of inflammatory factor expression and alleviation of chronic multi-organ inflammation.
These findings indicate that NR acts on multiple aging-related pathways and can, to a certain extent, delay degenerative changes in tissues and organs.
Part 03
Clearer Mechanisms of NR in Transcriptional Regulation and Tissue Targeting
Through bioinformatics analysis, the study further revealed differential gene expression changes induced by NR at the tissue level. The data showed that white adipose tissue (WAT), blood vessels, and the heart were particularly responsive to NR treatment, with more than 18% of aging-related genes being reversed following NR intervention.
Notably, NR significantly downregulated several transcription factors associated with inflammation and immune responses, such as Cebpb, Rela, and Stat2, thereby suppressing chronic inflammatory responses at the gene regulation level. This regulatory mechanism not only enhances the stability of NR in aging intervention but also highlights its tissue-targeted characteristics as a therapeutic strategy.
Part 04
Safety and Controllability Support Expanding Applications and Industrialization
Unlike some anti-aging compounds, long-term use of NR in animal models did not result in obvious adverse effects. The research suggests that NR exhibits relatively clear tissue targeting and regulatory mechanisms, with controllable safety risks. This provides a solid foundation for its translation into functional foods, nutritional supplements, and medical-grade raw materials.
As one of the early domestic enterprises engaged in NAD⁺ precursor materials, Bontac Bioengineering (Shenzhen) Co., Ltd. has accumulated extensive experience in NR production and process optimization. Its NR products feature high purity, low impurity levels, and customizable specifications, meeting a wide range of needs from dietary supplements to scientific research applications.
With the gradual disclosure of more NR-related patents and continued technological advancement among upstream raw material suppliers, the technical maturity of NR is steadily improving, and its role in human health intervention is expected to become increasingly clear.
Conclusion
As a key precursor in the NAD⁺ metabolic pathway, NR has progressed from basic research to patent protection and has demonstrated multidimensional anti-aging potential at both tissue and gene levels. Driven jointly by scientific research and industry development, its application in the field of healthy aging is gradually moving toward preclinical validation and practical product development.For individuals concerned with cellular health, tissue function, and chronic inflammation control, NR is expected to become a more standardized and scientifically grounded nutritional intervention option in the future.
